Targeting lactate dehydrogenase a improves radiotherapy efficacy in non-small cell lung cancer: from bedside to bench

BACKGROUND: Lactate dehydrogenase A (LDHA) is overexpressed and associated with poor prognosis in many kinds of cancer. In the current study, we evaluated the prognostic value of LDHA expression in non-small cell lung cancer (NSCLC), and tested whether LDHA inhibition might improve radiotherapy effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Chong, Yu, Chen, Mengyuan, Dai, Wumin, Zhou, Xia, Ji, Yongling, Qiu, Guoqin, Du, Xianghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074241/
https://www.ncbi.nlm.nih.gov/pubmed/33902615
http://dx.doi.org/10.1186/s12967-021-02825-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074241/
https://www.ncbi.nlm.nih.gov/pubmed/33902615
http://dx.doi.org/10.1186/s12967-021-02825-2

Ejemplares similares